fda
76 records
FDA Drug Recall: INJECTAFER 720 MG in 100 ml NS IVPB; INJECTAFER 210 MG in 100 ml NS IVPB, Rx Onl
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Adcetris 96 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, B
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DIPHENHYDRAMINE 25 MG/50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave,
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DOCETAXEL 60 MG / 250 ml D5W IVPB; DOCETAXEL 71 MG/ 250 ML NS IVPB; DOCETAXEL 15
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TOPOTECAN 1.24 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the A
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 1
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Fluorouracil 560 MG / 11.2 ML IVP Fluorouracil 3340 MG QS 92 ML 0.9% NACL Fluo
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: GAZYVA 100 MG IN 250 ML NS IVPB; GAZYVA 900 MG IN 250 ML NS IVPB, Rx Only, Infus
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Gemcitabine 1910 MG / 250 ML NS IVPB; Gemcitabine 1140 MG / 250 ML NS 0.9% IVPB;
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: LEUCOVORIN 560 MG / 250 ML NS IVPB; LEUCOVORIN 830 MG / 250 ml NS IVPB; LEUCOVOR
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: HERCEPTIN 400 MG / 250 ML NS IVPB; HERCEPTIN 340 MG /250 ml 0.9% NACL IVPB; HERC
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: SOLIRIS 1200 MG QS 240 ML NACL0.9% IVPB; SOLIRIS 900 MG QS 180 ML NACL 0.9% IVPB
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: TRASTUZUMAB 427 MG / 250 ml NS IVPB; TRASTUZUMAB 531 MG / 250 ML NS IVPB; TRASTU
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: InFLIXimab 300 mg / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: OPDIVO 200 mg /100 ML NS VPB; OPDIVO 480 mg/100 ML NS IVPB, Rx Only, Infusion Op
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PACLITAXEL 258 MG / 500 ML NS IVPB; PACLITAXEL 318 MG / 500 ML NS IVPB; PACLITAX
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: AVASTIN 630 MG / 100 ML 0.9% NACL IVPB; AVASTIN 2.5 mg/ 0.1ML Syringe; AVASTIN 5
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PERJETA 420 MG/250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: IRINOTECAN 250 MG /500 ml D5W IVPB; IRINOTECAN 110 MG /250 ML D5W IVPB; IIRINOTE
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: GRANISETRON 1000 MCG / 50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave,
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: VINCRISTINE 1 MG /50 ML NS IVPB; VINCRISTINE 1.2 MG /50 ML NACL 0.9% IVPB; VINCR
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Cytarabine 128 MG/250 ML D5W IVPB; Cytarabine 20 MG / 1 ML SQ SYRINGE Cytarabin
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Cyclophosphamide 840 MG / 250 ML NS IVPB; Cyclophosphamide 1112 MG / 250 ML NS I
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ADO-TRASTUZUMAB 210 MG/250 ml NS; ADO-TRASTUZUMAB E 213 MG / 250 ML NS; ADO-TRAS
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ATEZOLIZUMAB 1200 MG / 250 ML 0.9% NACL, Rx Only, Infusion Options, Inc. 5924 13
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PACLITAXEL PROTEIN 175 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 190 MG/100 ML NS IV
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PRESERVATIVE FREE 0.9% NACL 5 ML SYR, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CARFILZOMIB 65 MG IN 50 ML D5W IVPB; CARFILZOMIB 75 MG IN 50 ML D5W IVPB; CARFIL
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMET
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BEVACIZUMAB 784 MG / 100 ML NS IVPB; BEVACIZUMAB 350 MG/100 ml NS IVPB; BEVACIZU
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Etoposide 184 MG / 500 ml NS IVPB; Etoposide 176 MG/ 500 ml 0.9% NACL IVPB; Etop
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ENTYVIO 300 MG /250 ML 0.9% NACL, Rx Only, Infusion Options, Inc. 5924 13the Ave
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: REMICADE 680 MG QS 250 ML 0.9% NACL IVPB; REMICADE 270 MG QS 250 ML 0.9% NACL IV
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: METHOTREXATE 25 MG / 1 ML IM SYR; METHOTREXATE 12 mg QS 5 ml PF 0.9% NACL; METHO
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Sodium Chloride 0.9% 1 LITER WITH Potassium Chloride 20 mEq, Mannitol 12.5 G, Ma
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DEXAMETHASONE 10 MG / 50 ML NS IVPB; DEXAMETHASONE 5 MG / 50 ML NS; DEXAMETHASON
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DACARBAZINE 680 MG in 250 ml NS; DACARBAZINE 675 MG in 250 ml NS, Rx Only, Infus
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RAMUCIRUMAB 457 MG QS 250 ML NS IVPB; AMUCIRUMAB 1182 MG QS 250 ML NS IVPB; Rx O
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: IFOSFAMIDE 9200 MG / 1 L NS IVPB WITH MESNA 9200 MG, Rx Only, Infusion Options,
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Doxorubicin 110 MG / 55 ML IVP SYRINGE; Doxorubicin 56 MG / 28 ML IVP SYRINGE; D
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPB; PACLITAXEL ALBUMIN 160 MG / 100 ml NS
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Durvalumab 651 mg/ 250 ml NS IVPB; Durvalumab 650 mg/ 250 ml NS IVPB, Rx Only, I
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: IRON SUCROSE 200 mg / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BORTEZOMIB 2.5 mg / 1 ML SQ SYRINGE; BORTEZOMIB 2.88 MG / 1.15 ML SQ SYRINGE; BO
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RITUXAN 728 MG QS 728 mL 0.9% NACL IVPB; RITUXAN 560 MG / 306 ml 0.9% NACL; RI
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Doxorubicin Liposomal 71 MG / 250 ML D5W IVPB; Doxorubicin Liposomal 66 MG/250 M
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ERBITUX 770 MG/ 385 ML IVPB; ERBITUX 440 MG/ 220 ml IVPB; ERBITUX 850 MG/ 425
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: METHYLPREDNISOLONE 10 MG / 0.16 ML IVP, Rx Only, Infusion Options, Inc. 5924 13t
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: VINBLASTINE 10.9 MG / 100 ML D5W IVPB; VINBLASTINE 10.8 MG / 100 ML D5W IVPB, Rx
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DARATUMUMAB 904 MG QS 500 ML NS IVPB; DARATUMUMAB 668 MG QS 1000 ML NS IVPB, Rx
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ALIMTA 785 mg QS 100 ml 0.9% NACL IVPB; ALIMTA 1000 mg QS 100 ml 0.9% NACL IVPB;
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PERTUZUMAB 840 MG/250 ml0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13t
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: FOSAPREPITANT 150 mg/150 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ONDANSETRON 8 MG / 50 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: MITOMYCIN 10 MG /20 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the A
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: BLEOMYCIN 18 UNITS / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RomiPLOStim 700 MCG/ 1.4 ML SQ SYR, Rx Only, Infusion Options, Inc. 5924 13the A
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: NIVOLUMAB 480 MG / 100 ML NS IVPB; NIVOLUMAB 200 mg / 100 ML NS IVPB; NIVOLUMAB
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: AZACITIDINE 125 MG / 5 ML SUB-Q SYRINGE; AZACITIDINE 75 MG (3 ML) SYRINGE, AZACI
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 675 MG / 250 ml 0.9% NACL IV
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PANITUMUMAB 400 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DARZALEX 1008 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Av
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Oxytocin 60 units/1000 mL Lactated Ringers Intravenous Solution, Rx Only, Infusi
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CARBOPLATIN 174 MG / 250ml NS IVPB; CARBOPLATIN 240 MG / 250 ML NS IVPB; CARBOPL
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: Fluorouracil 560 MG / 11.2 ML IVP; Fluorouracil 3340 MG QS 92 ML 0.9% NACL; Fluo
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: DECITABINE 40 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Av
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: ERIBULIN 1.12 MG / 100 ML NS IVPB; ERIBULIN 1.87 MG / 100 ML NS IVPB; ERIBULIN
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CETUXIMAB 335 MG / 167.5 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALI
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
FDA Drug Recall: PEMBROLIZUMAB 200 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13th
2019-08-21
Class II — Lack of Assurance of Sterility
View Source
nppes
1 records
ny_corps
1 records
NY Corp: INFUSION OPTIONS, INC.
1985-05-21
DOMESTIC BUSINESS CORPORATION | County: Kings | Jurisdiction: New York
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.